PH31058A - Methods and preparations for preventing adhesions to organs and parts of organs. - Google Patents

Methods and preparations for preventing adhesions to organs and parts of organs.

Info

Publication number
PH31058A
PH31058A PH37880A PH37880A PH31058A PH 31058 A PH31058 A PH 31058A PH 37880 A PH37880 A PH 37880A PH 37880 A PH37880 A PH 37880A PH 31058 A PH31058 A PH 31058A
Authority
PH
Philippines
Prior art keywords
organs
parts
preparations
methods
preventing adhesions
Prior art date
Application number
PH37880A
Other languages
English (en)
Inventor
Helmut Dr Franz
Thomas Dr Muller
Eisert Wolfgang
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of PH31058A publication Critical patent/PH31058A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)
PH37880A 1987-12-04 1988-12-02 Methods and preparations for preventing adhesions to organs and parts of organs. PH31058A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873741149 DE3741149A1 (de) 1987-12-04 1987-12-04 Zubereitungsformen zur verhinderung von adhaesionen von organen und organteilen

Publications (1)

Publication Number Publication Date
PH31058A true PH31058A (en) 1998-02-05

Family

ID=6341894

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37880A PH31058A (en) 1987-12-04 1988-12-02 Methods and preparations for preventing adhesions to organs and parts of organs.

Country Status (18)

Country Link
US (1) US5578305A (ko)
EP (1) EP0318801B1 (ko)
JP (1) JP2741767B2 (ko)
KR (1) KR970010545B1 (ko)
AT (1) ATE67678T1 (ko)
AU (1) AU622632B2 (ko)
CA (1) CA1330298C (ko)
DE (2) DE3741149A1 (ko)
DK (1) DK167049B1 (ko)
ES (1) ES2037803T3 (ko)
GR (1) GR3003156T3 (ko)
HK (1) HK181596A (ko)
HU (1) HU201476B (ko)
IE (1) IE61464B1 (ko)
IL (1) IL88564A (ko)
NZ (1) NZ227183A (ko)
PH (1) PH31058A (ko)
ZA (1) ZA889048B (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE462829B (sv) * 1989-01-10 1990-09-10 Kabigen Ab Trombolytiskt aktiva kompositioner innehaallande en modifierad plasminogenaktivator av vaevnadstyp samt en normal human t-pa, streptokinas eller humant urokinas
DE19529223A1 (de) * 1995-08-09 1997-02-13 Boehringer Mannheim Gmbh Verwendung von Plasminogenaktivatoren zum lokalen Knochenaufbau
EP0887076A3 (en) * 1997-05-07 1999-03-31 Saturnus A.G. Adhesion prevention and an endoscopic insufflation system therefor
US20040153027A1 (en) 2002-10-28 2004-08-05 Mantell Robert R. Dual-capacity insufflator tube
US7654975B2 (en) * 2003-04-24 2010-02-02 Northgate Technologies, Inc. Mixed-gas insufflation system
ITMI20031640A1 (it) * 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
WO2005035035A1 (en) * 2003-10-07 2005-04-21 Northgate Technologies Inc. System and method for delivering a substance to a body cavity
EP1680173B1 (en) 2003-10-31 2011-01-12 Trudell Medical International System for manipulating a catheter for delivering a substance to a body cavity
EP1809303B1 (en) * 2004-09-23 2019-03-06 ARC Medical Devices, Inc. Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
JP2009545417A (ja) 2006-08-04 2009-12-24 ノースゲート テクノロジーズ インコーポレイテッド 体内へアクセスするための留置ポート
US9572595B1 (en) 2014-03-05 2017-02-21 Northgate Technologies Inc. In-dwelling port for access into a body
DE102014112212A1 (de) 2014-08-26 2016-03-03 Akesion Gmbh Rekombinante Fusionsproteine zur Vorbeugung oder Behandlung von Adhäsionen bei Geweben oder Organen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346108A (en) * 1981-06-22 1982-08-24 The Upjohn Manufacturing Company M Method for preventing adhesion formation
GR79202B (ko) * 1982-05-05 1984-10-22 Genentech Inc
EP0112852B1 (en) * 1982-06-24 1988-06-08 SMITH, Robert Alan Pharmaceutical gel composition
EP0174835A1 (en) * 1984-09-11 1986-03-19 The Upjohn Company Human tissue plasminogen activator and recombinant DNA compounds
US4889722A (en) * 1985-12-16 1989-12-26 Ethicon, Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator
AU586306B2 (en) * 1985-12-16 1989-07-06 Ethicon Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator
GB8613689D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
IL86933A (en) * 1987-07-01 1993-07-08 Genentech Inc Method and therapeutic compositions for the prevention of fibrin deposition for adhesions
US5364622A (en) * 1987-12-04 1994-11-15 Dr. Karl Thomae Gmbh Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
SE8900586L (sv) * 1989-02-21 1990-08-22 Pharmacia Ab Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader

Also Published As

Publication number Publication date
HUT49289A (en) 1989-09-28
NZ227183A (en) 1991-07-26
AU622632B2 (en) 1992-04-16
DK672488A (da) 1989-06-05
DE3741149A1 (de) 1989-06-15
IL88564A0 (en) 1989-07-31
ES2037803T3 (es) 1993-07-01
US5578305A (en) 1996-11-26
EP0318801A3 (en) 1989-08-09
DK167049B1 (da) 1993-08-23
JP2741767B2 (ja) 1998-04-22
EP0318801B1 (de) 1991-09-25
AU2648588A (en) 1989-06-08
IE883608L (en) 1989-06-04
ATE67678T1 (de) 1991-10-15
HK181596A (en) 1996-10-04
ZA889048B (en) 1990-08-29
KR970010545B1 (ko) 1997-06-28
IE61464B1 (en) 1994-11-02
EP0318801A2 (de) 1989-06-07
IL88564A (en) 1994-12-29
JPH01193230A (ja) 1989-08-03
HU201476B (en) 1990-11-28
DE3865182D1 (ko) 1991-10-31
DK672488D0 (da) 1988-12-02
GR3003156T3 (en) 1993-02-17
KR890009408A (ko) 1989-08-01
CA1330298C (en) 1994-06-21

Similar Documents

Publication Publication Date Title
PH31058A (en) Methods and preparations for preventing adhesions to organs and parts of organs.
DE3883985D1 (de) Ärztliches instrument und dessen herstellung.
AU2382588A (en) Medical instrument and production thereof
AU2080988A (en) Esters of 13-trans-retinoic acid
EP0653192A3 (de) Hochfrequenz-Chirurgiegerät zum Schneiden und/oder Koagulieren biologischer Gewebe.
AP9100310A0 (en) Tnf inhibitors
HU911185D0 (en) Process for the production of liposomic medical preparations with peptide-contain and deferred effect
CA2016575A1 (en) Method of aiding cessation of smoking
USD308725S (en) Base for medical instrument stand
AU2807689A (en) Method for the treatment of body tissues and the administration of drugs thereto
CA2060560A1 (en) Method for insuring adequate intracellular glutathione in tissue
AU6932691A (en) Administration method of antithrombin
GR3006674T3 (ko)
GR3006236T3 (ko)
AU1200488A (en) Protein c inhibitor (pci) as pharmaceutical and in vitro diagnostic aid, a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci
EP0276385A3 (en) Painless comminution of concretions
DE3569469D1 (en) Use of phytosterolglycosides for the preparation of medicaments for treatment of elevated 5(6)alpha-epoxycholesterol levels
NO960347L (no) Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
GB8722554D0 (en) Photosynthesis in men's blood to cure cancer
Lew Streptokinase in acute MI. Post-therapy management.
IL86887A (en) METHODS OF PRODUCING PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS USEFUL IN THE TREATMENT OF VASCULAR DISEASE AND PROVIDING VARIANTS OF HUMAN PLASMINOGEN ACTIVATOR (t-PA) AND PHARMACEUTICAL COMPOSITIONS PREPARED BY SUCH METHODS
史正修 OBSERVATION ON THE THERAPEUTIC EFFECT OF 120 CASES OF HALLUCINATION TREATED WITH AURICULAR ACUPUNCTURE
UA30011A (uk) Спосіб профілактики гострих стресових уражень шлунково-кишкового тракту після порожнинних оперативних втручань
JPS54113412A (en) Surgical medicine for skin disease such as dermatophytosis and like